These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27744625)

  • 1. Clinical Roles of Interleukin-6 and STAT3 in Oral Squamous Cell Carcinoma.
    Shinagawa K; Yanamoto S; Naruse T; Kawakita A; Morishita K; Sakamoto Y; Rokutanda S; Umeda M
    Pathol Oncol Res; 2017 Apr; 23(2):425-431. PubMed ID: 27744625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence and cancer-specific survival according to the expression of IL-4Rα and IL-13Rα1 in patients with oral cavity cancer.
    Kwon M; Kim JW; Roh JL; Park Y; Cho KJ; Choi SH; Nam SY; Kim SY; Lee BH
    Eur J Cancer; 2015 Jan; 51(2):177-85. PubMed ID: 25483786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipopolysaccharide-squamous cell carcinoma-monocyte interactions induce cancer-supporting factors leading to rapid STAT3 activation.
    Kurago ZB; Lam-ubol A; Stetsenko A; De La Mater C; Chen Y; Dawson DV
    Head Neck Pathol; 2008 Mar; 2(1):1-12. PubMed ID: 19603082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells-derived IL-6 promotes invasion and metastasis of oral squamous cell carcinoma via JAK-STAT3 signalling.
    Liu C; Zhou J; Zhang S; Fu J; Li Y; Hao Y; Yuan J; Tang F; Ge W; He H; Chen Q
    Oral Dis; 2024 May; 30(4):2097-2109. PubMed ID: 37249062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemerin promotes invasion of oral squamous cell carcinoma by stimulating IL-6 and TNF-α production via STAT3 activation.
    Lu Z; Liu J; Wan Q; Wu Y; Wu W; Chen Y
    Mol Biol Rep; 2024 Mar; 51(1):436. PubMed ID: 38520551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-22 promotes the migration and invasion of oral squamous cell carcinoma cells.
    Komine-Aizawa S; Aizawa S; Takano C; Hayakawa S
    Immunol Med; 2020 Sep; 43(3):121-129. PubMed ID: 32546118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-O-Methylmagnolol Induces Apoptosis and Inhibits IL-6/STAT3 Signaling in Oral Squamous Cell Carcinoma.
    Wang TH; Fang JY; Wu SJ; Liu YW; Chan CW; Chuang SY; Chen CY
    Cell Physiol Biochem; 2018; 50(3):883-892. PubMed ID: 30355952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemosensitizing effect of honokiol in oral carcinoma stem cells via regulation of IL-6/Stat3 signaling.
    Chang MT; Lee SP; Fang CY; Hsieh PL; Liao YW; Lu MY; Tsai LL; Yu CC; Liu CM
    Environ Toxicol; 2018 Nov; 33(11):1105-1112. PubMed ID: 30076764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humanized anti-interleukin-6 receptor antibody suppresses tumor angiogenesis and in vivo growth of human oral squamous cell carcinoma.
    Shinriki S; Jono H; Ota K; Ueda M; Kudo M; Ota T; Oike Y; Endo M; Ibusuki M; Hiraki A; Nakayama H; Yoshitake Y; Shinohara M; Ando Y
    Clin Cancer Res; 2009 Sep; 15(17):5426-34. PubMed ID: 19706815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary Immunosuppressive Cytokines IL-10 and IL-13 Are Significantly Elevated in Oral Squamous Cell Carcinoma Patients.
    Aziz S; Ahmed SS; Ali A; Khan FA; Zulfiqar G; Iqbal J; Khan AA; Shoaib M
    Cancer Invest; 2015; 33(7):318-28. PubMed ID: 26046681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of interleukin-6 predicts poor response to chemoradiotherapy and unfavorable prognosis in oral squamous cell carcinoma.
    Jinno T; Kawano S; Maruse Y; Matsubara R; Goto Y; Sakamoto T; Hashiguchi Y; Kaneko N; Tanaka H; Kitamura R; Toyoshima T; Jinno A; Moriyama M; Oobu K; Kiyoshima T; Nakamura S
    Oncol Rep; 2015 May; 33(5):2161-8. PubMed ID: 25761055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor microenvironment and Oral Squamous Cell Carcinoma: A crosstalk between the inflammatory state and tumor cell migration.
    Alves A; Diel L; Ramos G; Pinto A; Bernardi L; Yates J; Lamers M
    Oral Oncol; 2021 Jan; 112():105038. PubMed ID: 33129055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 as a therapy target in oral squamous carcinoma.
    Culig Z
    Expert Opin Ther Targets; 2013 Jan; 17(1):53-9. PubMed ID: 23101455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of STAT3 expression, signaling and inhibition in feline oral squamous cell carcinoma.
    Brown ME; Bear MD; Rosol TJ; Premanandan C; Kisseberth WC; London CA
    BMC Vet Res; 2015 Aug; 11():206. PubMed ID: 26272737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT3 signal transduction through interleukin-22 in oral squamous cell carcinoma.
    Naher L; Kiyoshima T; Kobayashi I; Wada H; Nagata K; Fujiwara H; Ookuma YF; Ozeki S; Nakamura S; Sakai H
    Int J Oncol; 2012 Nov; 41(5):1577-86. PubMed ID: 22922995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
    Fang CY; Liew PL; Chen CL; Lin YH; Fang CL; Chen WY
    Anticancer Res; 2017 Apr; 37(4):1891-1899. PubMed ID: 28373457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor for advanced glycation end products (RAGE) is important in the prediction of recurrence in human oral squamous cell carcinoma.
    Sasahira T; Kirita T; Bhawal UK; Yamamoto K; Ohmori H; Fujii K; Kuniyasu H
    Histopathology; 2007 Aug; 51(2):166-72. PubMed ID: 17593216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tunicamycin-induced endoplasmic reticulum stress up-regulates tumour-promoting cytokines in oral squamous cell carcinoma.
    Yakin M; Seo B; Rich A
    Cytokine; 2019 Aug; 120():130-143. PubMed ID: 31071674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma.
    St John MA; Li Y; Zhou X; Denny P; Ho CM; Montemagno C; Shi W; Qi F; Wu B; Sinha U; Jordan R; Wolinsky L; Park NH; Liu H; Abemayor E; Wong DT
    Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):929-35. PubMed ID: 15313862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of interleukin-6 and interleukin-6 receptor expressions in oral squamous cell carcinoma.
    Wang YF; Chang SY; Tai SK; Li WY; Wang LS
    Head Neck; 2002 Sep; 24(9):850-8. PubMed ID: 12211049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.